Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HOLSTEBRO ØJENKLINIK I/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7%   Bankruptcy risk   3.8% 2.8% 2.7% 2.7% 3.1% 2.9% 10.5% 5.9%   Credit score (0-100)   53 61 61 60 55 58 22 39   Credit rating   BBB BBB BBB BBB BBB BBB BB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,837 7,002 6,505 8,094 10,231 11,392 0.0 0.0   EBITDA   4,228 3,770 3,368 4,322 6,359 7,401 0.0 0.0   EBIT   3,937 3,465 3,150 4,166 6,231 7,327 0.0 0.0   Pre-tax profit (PTP)   3,924.7 3,449.0 3,136.2 4,148.8 6,202.6 7,301.9 0.0 0.0   Net earnings   3,924.7 3,449.0 3,136.2 4,148.8 6,202.6 7,301.9 0.0 0.0   Pre-tax profit without non-rec. items   3,925 3,449 3,136 4,149 6,203 7,302 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   772 849 752 596 467 393 0.0 0.0   Shareholders equity total   1,476 1,625 1,391 2,390 4,182 4,859 4,859 4,859   Interest-bearing liabilities   3.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0   Balance sheet total (assets)   2,148 2,314 2,414 3,352 4,676 5,258 4,859 4,859   Net Debt   -640 -767 -771 -1,796 -3,169 -3,593 -4,859 -4,859     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,837 7,002 6,505 8,094 10,231 11,392 0.0 0.0   Gross profit growth   0.1% 2.4% -7.1% 24.4% 26.4% 11.3% -100.0% 0.0%   Employees   6 6 6 6 7 7 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 16.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,148 2,314 2,414 3,352 4,676 5,258 4,859 4,859   Balance sheet change%   -14.0% 7.8% 4.3% 38.8% 39.5% 12.4% -7.6% 0.0%   Added value   3,937.0 3,464.7 3,150.4 4,165.5 6,230.9 7,327.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -557 -227 -314 -313 -257 -148 -393 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   57.6% 49.5% 48.4% 51.5% 60.9% 64.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   169.5% 155.3% 133.2% 144.5% 155.2% 147.5% 0.0% 0.0%   ROI %   219.1% 223.2% 208.9% 215.7% 187.1% 162.0% 0.0% 0.0%   ROE %   218.6% 222.5% 208.0% 219.5% 188.7% 161.5% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   68.7% 70.2% 57.6% 71.3% 89.4% 92.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -15.1% -20.3% -22.9% -41.6% -49.8% -48.5% 0.0% 0.0%   Gearing %   0.2% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   795.9% 1,011.3% 0.0% 0.0% 1,022.3% 909.4% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   2.0 2.1 1.6 3.1 8.5 12.2 0.0 0.0   Current Ratio   2.0 2.1 1.6 3.1 8.5 12.2 0.0 0.0   Cash and cash equivalent   643.5 766.6 770.7 1,795.9 3,174.4 3,592.7 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   704.1 775.6 639.2 1,875.6 3,715.4 4,465.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   656 577 525 694 890 1,047 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   705 628 561 720 908 1,057 0 0   EBIT / employee   656 577 525 694 890 1,047 0 0   Net earnings / employee   654 575 523 691 886 1,043 0 0